Ann: Investor Conference Call, page-53

So I am thinking 'stay positive'...

Let's look at some upsides:

- We collected $94k last quarter from DoE, that proves DoE are able to pay for some of the seats.
- James said all existing customers have chosen to renew their subscriptions, this proves a quality product.
- Very low Opex spend from BoD - Average: $470k QoQ FY2018
- Zero Debt
- Latest R&D spend will be in this quarter at only $50k , very low product development costs.
- ~$3M cash on hand (provides working capital for at least 1.5 years)
- 100 seats to come from Singapore (if funding is provided) although a measly sale at least its market penetration - sales expected in our Q4
- Philippines JV to deliver seat sales this month - should show in our Q4
- Australian seat sales completed - further proof of product demand and sales conversion
- New White Paper started in Australia, "apparently" progressing much better than the U.S one.

Then of course with NAACP showing strong interest in KNM and having already completed their due diligence we should (hopefully? maybe? fingers crossed!) see accelerated seat sales.

And lastly UK expansion to try our luck in the EMEA markets.

The 'potential' is ..still.. there!